Pathophysiology of the Anemia of Malignancy

[1]  M. Buyse,et al.  Anemia in Children With Cancer Is Associated With Decreased Erythropoietic Activity and Not With Inadequate Erythropoietin Production , 1998 .

[2]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor. , 1996, Experimental hematology.

[3]  W. Hrushesky,et al.  Cisplatin-associated anemia: an erythropoietin deficiency syndrome. , 1995, The Journal of clinical investigation.

[4]  D. Henry,et al.  Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. , 1994, Seminars in oncology.

[5]  S. Marsters,et al.  Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. , 1994, Blood.

[6]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. , 1993, The Journal of clinical investigation.

[7]  L. Paddock,et al.  The Frequency of Red Cell Transfusion for Anemia in Patients Receiving Chemotherapy A Retrospective Cohort Study , 1993, American journal of clinical oncology.

[8]  M. Goldberg,et al.  EFFECT OF INFLAMMATORY CYTOKINES ON HYPOXIA-INDUCED ERYTHROPOIETIN PRODUCTION , 1992 .

[9]  E. Dessypris,et al.  Inhibition of human erythroid colony‐forming units by interleukin‐1 is mediated by gamma interferon , 1992, Journal of cellular physiology.

[10]  Mark J. Koury,et al.  Localization of cells producing erythropoietin in murine liver by in situ hybridization , 1991 .

[11]  E. Dessypris,et al.  Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. , 1990, The Journal of clinical investigation.

[12]  A. D’Andrea,et al.  Human erythropoietin receptor: cloning, expression, and biologic characterization. , 1990, Blood.

[13]  S. Piantadosi,et al.  Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.

[14]  A. Maxwell,et al.  Erythropoietin production in kidney tubular cells , 1990, British journal of haematology.

[15]  S. Koury,et al.  Purification of human blood burst‐forming units‐erythroid and demonstration of the evolution of erythropoietin receptors , 1990, Journal of cellular physiology.

[16]  D. Sears,et al.  The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. , 1989, The American journal of medicine.

[17]  M. Koury,et al.  Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration , 1989 .

[18]  J. Caro,et al.  Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. , 1989, Blood.

[19]  P. Furmanski,et al.  In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. , 1989, Blood.

[20]  J. Royston,et al.  Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. , 1989, The Quarterly journal of medicine.

[21]  M. Goldberg,et al.  Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. , 1988, Science.

[22]  F. Wendling,et al.  Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. , 1988, The Journal of clinical investigation.

[23]  M. Koury,et al.  Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. , 1988, Blood.

[24]  J. Tavernier,et al.  EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.

[25]  M A Goldberg,et al.  The regulated expression of erythropoietin by two human hepatoma cell lines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Arakawa,et al.  Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. , 1987, Biochemistry.

[27]  D. Williams,et al.  The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. , 1986, Journal of immunology.

[28]  G. Roodman,et al.  Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease. , 1983, Blood.

[29]  Lee Gr.  The anemia of chronic disease. , 1983, Seminars in hematology.

[30]  G. Sarosi,et al.  In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection , 1982, British journal of haematology.

[31]  N. Iscove,et al.  THE ROLE OF ERYTHROPOIETIN IN REGULATION OF POPULATION SIZE AND CELL CYCLING OF EARLY AND LATE ERYTHROID PRECURSORS IN MOUSE BONE MARROW , 1977, Cell and tissue kinetics.

[32]  R. Means.  Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia , 1995, Stem cells.

[33]  W. Jelkmann,et al.  Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. , 1992, Life sciences.

[34]  Abels Ri,et al.  Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. , 1992, Seminars in oncology.

[35]  J. Cook,et al.  Iron metabolism in man , 1979 .

[36]  J. Adamson,et al.  Analysis of erythropoiesis by erythroid colony formation in culture. , 1978, Blood cells.